Fuji Pharma Statistics

Total Valuation

Fuji Pharma has a market cap or net worth of EUR 205.57 million. The enterprise value is 349.02 million.

Market Cap	205.57M
Enterprise Value	349.02M

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	24.39M
Shares Outstanding	n/a
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.28M

Valuation Ratios

The trailing PE ratio is 11.36.

PE Ratio	11.36
Forward PE	n/a
PS Ratio	0.70
PB Ratio	0.77
P/TBV Ratio	1.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	19.29
EV / Sales	1.20
EV / EBITDA	n/a
EV / EBIT	11.93
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.69.

Current Ratio	1.53
Quick Ratio	0.76
Debt / Equity	0.69
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	17.00

Financial Efficiency

Return on equity (ROE) is 6.78% and return on invested capital (ROIC) is 4.17%.

Return on Equity (ROE)	6.78%
Return on Assets (ROA)	3.46%
Return on Invested Capital (ROIC)	4.17%
Return on Capital Employed (ROCE)	8.17%
Revenue Per Employee	177,758
Profits Per Employee	10,914
Employee Count	1,658
Asset Turnover	0.55
Inventory Turnover	1.36

Taxes

In the past 12 months, Fuji Pharma has paid 6.41 million in taxes.

Income Tax	6.41M
Effective Tax Rate	26.16%

Stock Price Statistics

The stock price has increased by +9.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+9.87%
50-Day Moving Average	7.90
200-Day Moving Average	8.40
Relative Strength Index (RSI)	67.19
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Fuji Pharma had revenue of EUR 294.72 million and earned 18.10 million in profits. Earnings per share was 0.74.

Revenue	294.72M
Gross Profit	118.53M
Operating Income	29.70M
Pretax Income	24.50M
Net Income	18.10M
EBITDA	n/a
EBIT	29.70M
Earnings Per Share (EPS)	0.74

Full Income Statement

Balance Sheet

The company has 40.81 million in cash and 186.42 million in debt, giving a net cash position of -145.61 million.

Cash & Cash Equivalents	40.81M
Total Debt	186.42M
Net Cash	-145.61M
Net Cash Per Share	n/a
Equity (Book Value)	268.68M
Book Value Per Share	11.02
Working Capital	100.37M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 40.22%, with operating and profit margins of 10.08% and 6.14%.

Gross Margin	40.22%
Operating Margin	10.08%
Pretax Margin	8.31%
Profit Margin	6.14%
EBITDA Margin	n/a
EBIT Margin	10.08%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.26, which amounts to a dividend yield of 3.15%.

Dividend Per Share	0.26
Dividend Yield	3.15%
Dividend Growth (YoY)	4.99%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	2.90%
Earnings Yield	8.80%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 27, 2018. It was a forward split with a ratio of 2.

Last Split Date	Jun 27, 2018
Split Type	Forward
Split Ratio	2

Scores

Fuji Pharma has an Altman Z-Score of 1.87 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.87
Piotroski F-Score	5